UK Study Finds Pulmonary Rehab for COPD Underutilized
Response: We were commissioned by the Chartered Society of Physiotherapy in the UK to undertake a piece of work to show the value of pulmonary rehabilitation in reducing exacerbations in COPD patients so that they could create a web based tool that ...
FDA clears first nebulized LAMA inhaler for COPD
Pharmacy Today, American Pharmacists Association, pharmacist.com
FDA has approved glycopyrrolate inhalation solution 25 mcg twice daily (Lonhala Magnair—Sunovion Pharmaceuticals) for maintenance treatment of airflow obstruction in adults with chronic obstructive pulmonary disease (COPD). It is the first nebulized ...
COPD: Utilizing Devices and Interventional Methods
Many patients with COPD, maybe not in New York but, certainly, in the Carolinas, have low literacy with this condition. We did picture books for the American College of Physicians, just like we do in diabetes, to try to help. We also use the principle ...
US and China Asthma and COPD Drugs Market Is Anticipated to Be Worth US $18.7 Bn over Forecast 2016-2024
Albany, NY -- (SBWIRE) -- 12/14/2017 -- Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the ...
Inhalation Spray-Based Drugs Market: Industry Growth Report and Forecast 2017 to 2025